$225 billion drug giant Novartis is taking a fresh approach to cancer treatment, and it could help prepare it for a ‘doomsday scenario’

Jan 23, 2019

$225 billion drug giant Novartis is taking a fresh approach to cancer treatment, and it could help prepare it for a ‘doomsday scenario’

Posted by Genevieve Klien in categories: biotech/medical, existential risks

Pharma giant Novartis is developing drugs that could prevent cancer before patients get it. One big question: how will we pay for them?

Comments are closed.

GETAS THREAT LEVEL: ELEVATED
FACEBOOK: 13,861 MEMBERS
LINKEDIN: 2,066 MEMBERS
TWITTER FEED: 31,691 MEMBERS
GETTR FEED: 39,482 MEMBERS

LIFEBOAT NEWS: 3,400 SUBSCRIBERS
GETAS ALERTS: 573 SUBSCRIBERS
BLOG: 119,920 POSTS
DONORS: 5,968

BOARDS: 2,934 MEMBERS
REPORTS: 74
PROGRAMS: 25
FORUMS: 24
QUOTES: 136

FIGHT AIDS: 3 MEMBERS
FOLDING@HOME: 15 MEMBERS
ROSETTA@HOME: 44 MEMBERS

© 2002–2024 Lifeboat Foundation